G1 THERAPEUTICS, INC. FIRST AMENDMENT TO SENIOR ADVISOR AGREEMENTSenior Advisor Agreement • November 1st, 2023 • G1 Therapeutics, Inc. • Pharmaceutical preparations • North Carolina
This First Amendment to the Senior Advisor Agreement (the “First Amendment”) is deemed effective as of September 20, 2023 (the “Effective Date”), by and between G1 Therapeutics, Inc., a Delaware corporation (the “Company”), and Mark A. Velleca, M.D., Ph.D. (the “Advisor”). All capitalized terms used in this First Amendment but not defined herein shall have the meanings ascribed to them in the Agreement (as defined below).
